Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Change in Account Payables (2023 - 2024)

Historic Change in Account Payables for BioLineRx (BLRX) over the last 2 years, with Q4 2024 value amounting to $711000.0.

  • BioLineRx's Change in Account Payables fell 7707.19% to $711000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$5.5 million, marking a year-over-year decrease of 19992.74%. This contributed to the annual value of -$5.5 million for FY2024, which is 19992.74% down from last year.
  • According to the latest figures from Q4 2024, BioLineRx's Change in Account Payables is $711000.0, which was down 7707.19% from -$586000.0 recorded in Q3 2024.
  • BioLineRx's 5-year Change in Account Payables high stood at $3.1 million for Q4 2023, and its period low was -$3.5 million during Q1 2024.